HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studies.

Abstract
Somatostatin derivative peptides previously designed for radiodiagnostic purposes (99mTc P829 or 99mTc depreotide) were reoptimized for radiotherapy of tumors with rhenium radioisotopes. An optimized pharmacophore peptide P1839 was derived by in vitro binding affinity assay to AR42J rat pancreatic tumor cell membranes. Peptides with chelating domains and their oxorhenium(V) complexes were tested in vitro for binding to NCI H69 human SCLC tumor membranes. Further optimization entailed radiolabeling with 99mTc and biodistribution in an AR42J xenograft mouse model. Kidney uptake was decreased substantially by removing positively charged residues. Neutral N3S diamide amine thiol chelators with no adjacent positive charges had the best overall properties. Substituting an aromatic amino acid into the chelator approximately doubled the tumor uptake. The final optimized peptide P2045 (39) radiolabeled with 99mTc exhibited increased tumor uptake ( approximately 25 %ID/g at 1.5 h), lower kidney uptake ( approximately 4.8 %ID/g at 1.5 h), and extensive urinary excretion (59 %ID at 1.5 h). Finally, comparison biodistribution studies between 99mTc and 188Re (39) showed a good correlation between the two metal complexes and demonstrated prolonged tumor retention (> or =24 h).
AuthorsJohn E Cyr, Daniel A Pearson, David M Wilson, Carol A Nelson, Mary Guaraldi, Michael T Azure, John Lister-James, Ludger M Dinkelborg, Richard T Dean
JournalJournal of medicinal chemistry (J Med Chem) Vol. 50 Issue 6 Pg. 1354-64 (Mar 22 2007) ISSN: 0022-2623 [Print] United States
PMID17315859 (Publication Type: Journal Article)
Chemical References
  • Chelating Agents
  • Organometallic Compounds
  • Peptides
  • Radioisotopes
  • Radiopharmaceuticals
  • Receptors, Somatostatin
  • Rhenium
  • Technetium
Topics
  • Animals
  • Cell Line, Tumor
  • Chelating Agents (chemical synthesis, chemistry)
  • Female
  • Humans
  • Isotope Labeling
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Organometallic Compounds (chemical synthesis, chemistry, pharmacokinetics)
  • Peptides (chemical synthesis, chemistry)
  • Radioisotopes
  • Radioligand Assay
  • Radiopharmaceuticals (chemical synthesis, chemistry, pharmacokinetics)
  • Rats
  • Receptors, Somatostatin (metabolism)
  • Rhenium
  • Structure-Activity Relationship
  • Technetium
  • Tissue Distribution
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: